4950%
Followers on X. Updated Sep 8, 2026
Loading...

Pliant Therapeutics X Follower Count

Pliant Therapeutics has 495 followers on X (formerly Twitter), roughly flat (+1.0%) over the past three months.

With 495 followers, Pliant Therapeutics has a smaller X following than industry peers like Amgen (118,730) and Gilead Sciences (72,322).

How Pliant Therapeutics’s X Growth Feeds the PLRX AI Score

X follower trends are particularly relevant for companies with strong direct-to-consumer brands or high-profile leadership. A follower count is not a stock price on its own, but for consumer-facing companies a sustained shift in following can reflect changing brand momentum. AltIndex feeds Pliant Therapeutics’s X following into the PLRX AI Score as one of 25+ alternative data signals, weighed against hiring, web traffic, sentiment, and fundamentals.

For Pliant Therapeutics’s reach on other platforms, see Pliant Therapeutics Instagram followers, TikTok followers, YouTube subscribers, and Facebook followers.

For real-time conversation volume, see PLRX X mentions. For other demand signals, see web traffic, app downloads, and Google Trends.

Month over Month X Followers

Jul 2026 494
Jun 2026 491
May 2026 491
Apr 2026 489
Mar 2026 489
Feb 2026 493
Get PLRX alerts in real-time
The moment the x followers trend turns, sentiment flips, or insiders trade.
Try Stock Alerts Free

Pliant Therapeutics X (Twitter) Followers: Frequently Asked Questions

Pliant Therapeutics has 495 followers (495) on X (formerly Twitter), based on AltIndex’s tracking of the company’s official X account.

Pliant Therapeutics's X following has been roughly flat (+1.0%) over the past three months. View the trend chart above for the full history.

X follower trends are most telling for companies with strong direct-to-consumer brands or high-profile leadership. No single data point predicts a stock on its own, but a sustained change in Pliant Therapeutics's following can reflect shifting public interest. That is why AltIndex combines Pliant Therapeutics's X following with web traffic, hiring, sentiment, and 20+ other signals in its AI Score rather than reading any one signal in isolation.

Pliant Therapeutics underperforms its industry peers when it comes to X Followers, ranking dead last.

With fewer than 1,000 followers, Pliant Therapeutics' X account is in its growth phase, focusing on building its audience. This suggests a niche but potentially dedicated following, important for targeted engagement.

Sign up and get more insights on Pliant Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.